BIOMODICS ApS
CVR 32887082 · Private limited company (ApS) · Active · Low risk
BIOMODICS ApS is a Private limited company (ApS), founded on , based in Kgs.Lyngby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 16 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 5.9m and a net result of DKK 2.4m. CEO: Peter Thomsen.
Bankruptcy risk for BIOMODICS ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32887082
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (16 years)
- Address
- Stengårds Alle 31A
2800 Kgs.Lyngby - Municipality
- Lyngby-Taarbæk
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 80k
- Employees
- 4 (2018)
- Auditor
- REVISIONSFIRMAET POUL REXEN THOMSEN ApS
- Audit opted out
- No
Warning signs
| Annual reports filed late | 3 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 58.7% |
| Current ratio | 228% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 5.9m | DKK 3.7m | DKK 2.8m |
| Net profit | DKK 2.4m | DKK 482k | DKK 392k |
| Equity | DKK 5.9m | DKK 3.5m | DKK 3.0m |
| Total assets | DKK 10.1m | DKK 7.1m | DKK 6.7m |
| Cash | DKK 4.1m | DKK 4.3m | – |
| Short-term debt | DKK 4.2m | DKK 3.6m | – |
| Tax owed | DKK 681k | DKK 147k | – |
| Avg. employees | 3 | – | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · Revisionsfirmaet Poul Rexen Thomsen ApS.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 179 | ||
| 1 Jan 2024 – 31 Dec 2024 | 169 | ||
| 1 Jan 2023 – 31 Dec 2023 | 181 | ||
| 1 Jan 2022 – 31 Dec 2022 | 159 | ||
| 1 Jan 2021 – 31 Dec 2021 | 180 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 230 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 150 | ||
| 1 Jan 2015 – 31 Dec 2015 | 120 | ||
| 1 Jan 2014 – 31 Dec 2014 | 146 | ||
| 1 Jan 2013 – 31 Dec 2013 | 151 | ||
| 1 Jan 2012 – 31 Dec 2012 | 157 | ||
| 1 Jan 2011 – 31 Dec 2011 | 184 | Late | |
| 28 Apr 2010 – 31 Dec 2010 | 219 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Thomsen | Current | |
| Owner (100%) | PTT HOLDING ApS | Current | |
| Auditor | REVISIONSFIRMAET POUL REXEN THOMSEN ApS | Current | |
| Auditor | HAAMANN 1 A/S | ||
| Auditor | SMV REVISORERNE ApS | ||
| Auditor | Boye Rynord | ||
| Founder | Peter Thomsen | Current |
The CEOs' other companies
Peter Thomsen – 2 other companies
- BACTICON ApS Active
- PTT HOLDING ApS Active
Address history (0 moves)
| Stengårds Alle 31A, 2800 Kgs.Lyngby |
Employees per year
Other companies at the same address
- BACTICON ApS Active
- PIP Adviser ApS Active
- PTT HOLDING ApS Active
- VICH 4462 ApS Compulsorily dissolved
- Visi4 ApS Active
Similar companies in Lyngby-Taarbæk
- Munro Consulting ApS Kongens Lyngby
- Nykode Tolerance A/S Kongens Lyngby
- Mycoverse ApS Kongens Lyngby
- Enzidia ApS Kongens Lyngby
- Novo Nordisk Foundation Cellerator A/S Kongens Lyngby
- KLMBio ApS Virum
- MCT Bioseparation Aps Kongens Lyngby
- VenomAid Diagnostics ApS Kongens Lyngby
- Valinor Aps Kongens Lyngby
- GeCo ApS Kongens Lyngby
- Selma Diagnostics ApS Kongens Lyngby
- MonTa Biosciences ApS Kongens Lyngby
Questions and answers about BIOMODICS ApS
Has BIOMODICS ApS gone bankrupt?
No, BIOMODICS ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIOMODICS ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of BIOMODICS ApS?
Peter Thomsen is the CEO of BIOMODICS ApS.
Who is the auditor of BIOMODICS ApS?
BIOMODICS ApS most recently used REVISIONSFIRMAET POUL REXEN THOMSEN ApS.
When was BIOMODICS ApS founded?
BIOMODICS ApS was founded on 28 April 2010.
What is the equity of BIOMODICS ApS?
Equity was DKK 5.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.